CNBC's Brian Shactman reports JP Morgan shares are down almost 7% in after-hours trading; Yahoo's CEO says he didn't provide the company with a resume; and shares of Arena Pharmaceuticals soar as an FDA advisory panel approves its obesity drug.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT